Diagnostic Implications of Dupilumab‐Refractory Atopic Dermatitis: Risk of Underlying Cutaneous T‐Cell Lymphoma and the Role of Skin Biopsy

The data that support the findings of this study were obtained from the TriNetX Research Network and are available to other researchers upon request and with appropriate access permissions. De-identified aggregate-level data, a data dictionary describing the variables used, and the statistical code used for cohort creation and outcome assessment can be shared upon reasonable request to the corresponding author. Data access requires institutional credentials or collaboration with an institution that maintains a TriNetX license. Analyses may be replicated or extended within the TriNetX platform. There are no additional restrictions on the use of the shared materials beyond those imposed by the TriNetX user agreement.